Literature DB >> 9435620

Regulatory effects of phospholamban on cardiac function in intact mice.

J N Lorenz1, E G Kranias.   

Abstract

Phospholamban (PLB) regulates Ca(2+)-adenosinetriphosphatase activity in cardiac sarcoplasmic reticulum and participates in the regulation of myocardial performance. Animal models with altered levels of PLB permit in vivo evaluation of the physiological role of PLB. This study examined left ventricular (LV) performance in intact PLB heterozygous and homozygous mice under basal and stimulated conditions. A Millar Mikro-Tip transducer was inserted into the right carotid artery and advanced into the LV for direct measurement of ventricular pressure and the first derivative of intraventricular pressure (dP/dt). Baseline blood pressures were increased in PLB heterozygotes and even more so in PLB homozygotes compared with wild types (WT), and there were no differences in heart rate or LV end-diastolic pressure. The increase in pressure was primarily caused by an increase in systolic pressure. Baseline values for positive and negative dP/dt were linearly correlated with PLB levels. In PLB heterozygotes, contractile response to isoproterenol (Iso) was blunted compared with WT, but maximum rates of contraction were similar between the two groups. Contractile performance in PLB homozygous mice, which under baseline conditions was similar to maximum levels seen in WT, showed a blunted response to Iso, and maximum rates of contraction were significantly greater than in either of the other groups, indicating an essential but perhaps not exclusive role for PLB in mediating the inotropic effects of beta-adrenergic agonists. The effects of Iso on negative dP/dt were also blunted in both PLB heterozygous and PLB homozygous animals. Our results demonstrate that myocardial function in highly dependent on PLB level and suggest that the cardiovascular effects of PLB perturbations are largely uncompensated for in the intact mouse.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9435620     DOI: 10.1152/ajpheart.1997.273.6.H2826

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

1.  Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy.

Authors:  K Freeman; I Lerman; E G Kranias; T Bohlmeyer; M R Bristow; R J Lefkowitz; G Iaccarino; W J Koch; L A Leinwand
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

Review 2.  Phospholamban interactome in cardiac contractility and survival: A new vision of an old friend.

Authors:  Kobra Haghighi; Philip Bidwell; Evangelia G Kranias
Journal:  J Mol Cell Cardiol       Date:  2014-10-18       Impact factor: 5.000

3.  Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice.

Authors:  Scott P Heximer; Russell H Knutsen; Xiaoguang Sun; Kevin M Kaltenbronn; Man-Hee Rhee; Ning Peng; Antonio Oliveira-dos-Santos; Josef M Penninger; Anthony J Muslin; Thomas H Steinberg; J Michael Wyss; Robert P Mecham; Kendall J Blumer
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

Review 4.  Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome.

Authors:  Evangelia G Kranias; Roger J Hajjar
Journal:  Circ Res       Date:  2012-06-08       Impact factor: 17.367

5.  Adrenergic regulation of cardiac contractility does not involve phosphorylation of the cardiac ryanodine receptor at serine 2808.

Authors:  Scott M MacDonnell; Gerardo García-Rivas; Joseph A Scherman; Hajime Kubo; Xiongwen Chen; Héctor Valdivia; Steven R Houser
Journal:  Circ Res       Date:  2008-04-03       Impact factor: 17.367

6.  Full-length dystrophin expression in half of the heart cells ameliorates beta-isoproterenol-induced cardiomyopathy in mdx mice.

Authors:  Yongping Yue; Jeffrey W Skimming; Mingju Liu; Tammy Strawn; Dongsheng Duan
Journal:  Hum Mol Genet       Date:  2004-06-09       Impact factor: 6.150

7.  Correlations between alterations in length-dependent Ca2+ activation of cardiac myofilaments and the end-systolic pressure-volume relation.

Authors:  Grzegorz Nowak; James R Peña; Dalia Urboniene; David L Geenen; R John Solaro; Beata M Wolska
Journal:  J Muscle Res Cell Motil       Date:  2008-03-26       Impact factor: 2.698

Review 8.  The role of SERCA2a/PLN complex, Ca(2+) homeostasis, and anti-apoptotic proteins in determining cell fate.

Authors:  Elizabeth Vafiadaki; Vasiliki Papalouka; Demetrios A Arvanitis; Evangelia G Kranias; Despina Sanoudou
Journal:  Pflugers Arch       Date:  2008-04-16       Impact factor: 3.657

9.  Impairment of the ER/mitochondria compartment in human cardiomyocytes with PLN p.Arg14del mutation.

Authors:  Friederike Cuello; Anika E Knaust; Umber Saleem; Malte Loos; Janice Raabe; Diogo Mosqueira; Sandra Laufer; Michaela Schweizer; Petra van der Kraak; Frederik Flenner; Bärbel M Ulmer; Ingke Braren; Xiaoke Yin; Konstantinos Theofilatos; Jorge Ruiz-Orera; Giannino Patone; Birgit Klampe; Thomas Schulze; Angelika Piasecki; Yigal Pinto; Aryan Vink; Norbert Hübner; Sian Harding; Manuel Mayr; Chris Denning; Thomas Eschenhagen; Arne Hansen
Journal:  EMBO Mol Med       Date:  2021-05-16       Impact factor: 12.137

10.  In vivo imaging of macrophages during the early-stages of abdominal aortic aneurysm using high resolution MRI in ApoE mice.

Authors:  Yuyu Yao; Yuanyuan Wang; Yi Zhang; Yefei Li; Zulong Sheng; Song Wen; Genshan Ma; Naifeng Liu; Fang Fang; Gao-Jun Teng
Journal:  PLoS One       Date:  2012-03-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.